自然杀伤/T 细胞淋巴瘤的临床试验
总计6883个结果
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand Pharmaceuticals完全的
-
University of Texas Southwestern Medical Center撤销
-
University of BirminghamCelgene; Amgen; Bloodwise完全的
-
National Cancer Centre, SingaporeBristol-Myers Squibb撤销
-
Janssen Research & Development, LLC完全的淋巴瘤,T细胞,皮肤法国, 英国, 西班牙, 葡萄牙, 美国, 德国
-
The Lymphoma Academic Research Organisation完全的
-
Chonnam National University HospitalKyungpook National University Hospital未知
-
TG Therapeutics, Inc.SCRI Development Innovations, LLC完全的
-
Samsung Medical CenterAsan Medical Center; Yonsei University; Seoul National University; Chonnam National University完全的
-
Ruijin HospitalRenJi Hospital; West China Hospital; Shandong Provincial Hospital; Tianjin Medical University Cancer... 和其他合作者招聘中
-
Second Affiliated Hospital, School of Medicine,...Ningbo No. 1 Hospital; Jinhua Central Hospital; Huizhou Municipal Central Hospital招聘中
-
Shanghai Zhongshan HospitalTakeda; BeiGene尚未招聘NK/T 细胞淋巴瘤编号
-
Peking UniversityPeking University Cancer Hospital & Institute尚未招聘
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.招聘中
-
Antengene Corporation终止
-
Conjupro Biotherapeutics, Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.撤销
-
Eisai Co., Ltd.完全的
-
The University of Hong Kong未知
-
The First Affiliated Hospital of Soochow University未知
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.终止
-
Nanfang Hospital of Southern Medical University未知
-
Kyowa Hakko Kirin Pharma, Inc.完全的
-
Novartis完全的
-
University Hospital, GrenobleFrench Innovative Leukemia Organisation完全的